PD Dr. Matthias Rübner



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Placental thromboinflammation impairs embryonic survival by reducing placental thrombomodulin expression (2021) Kohli S, Singh KK, Gupta A, Markmeyer P, Lochmann F, Gupta D, Rana R, et al. Journal article Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program (2021) Muller V, Banys-Paluchowski M, Friedl TWP, Fasching P, Schneeweiss A, Hartkopf A, Wallwiener D, et al. Journal article Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis (2021) Hübner H, Lubrich H, Blum S, Antoniadis S, Lermann J, Ekici AB, Fasching P, et al. Journal article Association of genomic variants at PAX8 and PBX2 with cervical cancer risk (2021) Ramachandran D, Wang Y, Schuermann P, Huelse F, Mao Q, Jentschke M, Boehmer G, et al. Journal article Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany (2020) Hübner H, Kurbacher CM, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al. Journal article HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment (2020) Würfel F, Hübner H, Häberle L, Gaß P, Hein A, Jud S, Hack C, et al. Journal article HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer (2020) Würfel FM, Wirtz RM, Winterhalter C, Taffurelli M, Santini D, Mandrioli A, Veltrup E, et al. Journal article Piwi-like 1 and piwi-like 2 expression in breast cancer (2020) Erber R, Meyer J, Taubert H, Fasching P, Wach S, Häberle L, Gaß P, et al. Journal article Use of a molecular Registry (PRAEGNANT) for Patient-Selection and Biomarker-Analysis for the SHERBOC Study (2020) Hübner H, Kurbacher C, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al. Conference contribution Erratum: SNiPER: A novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection (Oncotarget. (2019) 10 (6494-6508) DOI: 10.18632/oncotarget.27303) (2020) Mijnes J, Tiedemann J, Eschenbruch J, Gasthaus J, Bringezu S, Bauerschlag D, Maass N, et al. Journal article, Erratum